Skip to main content
Main menu
About
Our Mission
Donors
Board of Directors
Advisory Boards
Staff
Careers
Who we are
FAQ
Annual Report
Why New TB Drugs?
Global Pandemic
Inadequate Treatment
Antimicrobial Resistance
Maternal and Child Health
Cycle of Poverty
R&D
Scientific Vision
Pipeline
Discovery
Engaging Communities
Access
Our Commitment
Access in TB Market
Child-friendly medicines
Pretomanid and BPaL
Pathways to Access BPaL
News
Latest News
Publications
Voices of TB
Research Papers
Making an Impact
Donate
Search form
Search
News Archive
April 3, 2005
World TB Day 2005
March 27, 2005
Better Drugs for Tuberculosis
March 25, 2005
Finding New Cures for TB
March 23, 2005
GSK Ties Up With TB Alliance on Drug Research
March 22, 2005
Tuberculosis stats drive search for new drugs
March 20, 2005
TB Alliance and GlaxoSmithKline Launch Broad Discovery Portfolio to Develop New TB Therapies
March 9, 2005
Global Alliance for TB Drug Development Appoints New Members to Board of Directors
March 6, 2005
MDG Update: Investing in Strategies to Reverse the Global Incidence of TB
March 6, 2005
Dr. Martien Borgdorff appointed Executive Director at KNCV
March 6, 2005
Dutch Development Agency Renews TB Alliance Funding with € 2 Million Grant
Pages
«
‹
…
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
…
›
»
